Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimmen Quan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Prostate|October 26, 2023
Disease control outcomes of stereotactic body radiation therapy or moderate hypo-fractionation for prostate cancer: Real-world experience at two Canadian centersHsin-Pei Hu, Gregory Anagnostopoulos, Mohammad Gouran-Savadkoohi, et al.
Clinical Genitourinary Cancer|April 9, 2020
A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806)Naghmeh Isfahanian, Himanshu Lukka, Ian Dayes, et al.
Clinical Lung Cancer|February 21, 2017
A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574)Nhu-Tram A Nguyen, Naghmeh Isfahanian, Gregory Pond, et al.
The Prostate|April 27, 2025
Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate CancerAndre Gouveia, Aruz Mesci, Naghmeh Isfahanian, et al.
Communications Medicine|April 28, 2025
Potential influence of geomagnetic activity on blood pressure statistical fluctuations at mid-magnetic latitudesPengzhi He, Chen Li, Minlan Xu, et al.
JAMA Oncology|September 19, 2024
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical TrialAnand Swaminath, Sameer Parpia, Marcin Wierzbicki, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2025
Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE TrialQirui Hou, Sameer Parpia, Marcin Wierzbicki, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Prostate|October 26, 2023
Disease control outcomes of stereotactic body radiation therapy or moderate hypo-fractionation for prostate cancer: Real-world experience at two Canadian centersHsin-Pei Hu, Gregory Anagnostopoulos, Mohammad Gouran-Savadkoohi, et al.
Clinical Genitourinary Cancer|April 9, 2020
A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806)Naghmeh Isfahanian, Himanshu Lukka, Ian Dayes, et al.
Clinical Lung Cancer|February 21, 2017
A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574)Nhu-Tram A Nguyen, Naghmeh Isfahanian, Gregory Pond, et al.
The Prostate|April 27, 2025
Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate CancerAndre Gouveia, Aruz Mesci, Naghmeh Isfahanian, et al.
Communications Medicine|April 28, 2025
Potential influence of geomagnetic activity on blood pressure statistical fluctuations at mid-magnetic latitudesPengzhi He, Chen Li, Minlan Xu, et al.
JAMA Oncology|September 19, 2024
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical TrialAnand Swaminath, Sameer Parpia, Marcin Wierzbicki, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2025
Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE TrialQirui Hou, Sameer Parpia, Marcin Wierzbicki, et al.
Pageof 3